RAC 2.92% $1.94 race oncology ltd

MST valuation of RAC, page-203

  1. 5,128 Posts.
    lightbulb Created with Sketch. 3118
    Some very low level remarks this morning .
    It isn’t ok to come in and be blatantly disrespectful & ignorant.

    Race Oncology has a very high calibre scientific team .
    And a CMO - busy and based in Texas at MD Anderson centre though . Prof Borje Andersson is also head of the global clinical advisory board & stepped up a lot to work with , and assist RAC in the last 18mths.

    An Australian based fulltime CMO is sought now to work with the entire global team and George Clinical consultants .

    I am mesmerised now thinking of the two French doctors , Drs Leverger & Bertrand ; as well as the author of the paper , Dr Amir Sharaf in mid 2018 .
    I wonder about their interactions now with Race Oncology?— and any facilitation for bisantrene trials again back ‘home’ in France ?

    It is unbelievable that bisantrene was lost immediately after the important 1994 Leblanc french paediatric trial - all due to the crazy corporate activity which occurred in America and the production facilities & IP etc all being completely dropped & lost.

    Intriguing to think of some of the original doctors and scientists then, and now others taking up the baton anew including especially in France .

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.